Literature DB >> 10396337

[Epidemic of respiratory tract infections by Mycoplasma pneumoniae in an institute for mentally disabled, investigated with polymerase chain reaction of a throat swab specimen].

J W Dorigo-Zetsma1, M de Wit, J S Szabó, P M Schneeberger.   

Abstract

OBJECTIVE: To determine the spread of respiratory infection with Mycoplasma pneumoniae in an institute for mentally disabled persons.
DESIGN: Descriptive.
METHODS: In the period from mid-April to mid-September in a certain year the transmission of M. pneumoniae in the facility was evaluated using questionnaires and laboratory investigations. The laboratory investigations consisted of an M. pneumoniae specific polymerase chain reaction (PCR) on throat swab specimens and detection of antibodies in serum.
RESULTS: 21 Residents and 26 staff members from 2/36 units were involved in the initial investigation. 17 Persons had complaints of a (recent) respiratory infection (cough, malaise and fever). In 9 cases an M. pneumoniae infection was confirmed, in 5 cases by PCR and in 4 cases by serology. Two PCR positive persons had only complaints of coughing. During the investigation period 2 more persons were diagnosed with a respiratory infection due to M. pneumoniae. No new cases were found by investigation of contacts outside the facility.
CONCLUSION: M. pneumoniae can cause an outbreak of M. pneumoniae respiratory infection in an institute for mentally disabled persons. Rapid detection of this pathogen is possible by PCR and is important for proper antibiotic therapy and epidemic-control measures.

Entities:  

Mesh:

Year:  1999        PMID: 10396337

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

1.  Pooled analysis of nuclear acid sequence-based amplification for rapid diagnosis of Mycoplasma pneumoniae infection.

Authors:  Chong Huang; Pei-Ting Huang; Jie-Ying Yao; Zhong-Wei Li; Luo-Bei Weng; Xu-Guang Guo
Journal:  J Clin Lab Anal       Date:  2019-03-06       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.